MEDIA

MEDIA - NEWS AND UPCOMING EVENTS

Media Contact:

Julie A. Fotheringham - Partner, Hageman Communications
Julie.fotheringham@hageman.ca  416-951-7988

NEWS ARCHIVES

Category:

In conversation with Tom Reeves
As CEO of Interface Biologics, Tom Reeves doesn’t dwell on what might have been. For example, a few years ago, as COO of OccuLogix, he came within the blink of an eye of a billion-dollar breakthrough to treat dry age-related macular degeneration.
Interface Biologics Expands Scientific Advisory Board
Interface Biologics Inc. (IBI), a privately held developer of novel biomedical-polymers for use in implantable medical devices, announced today the appointment of Dr. John Denstedt, Dr. Curtis Nickel and Dr. Leonard Pinchuk to its Scientific Advisory Boar
Antimicrobial-Infused Polymer Demonstrates Backbone
Implants often rely on antimicrobial coatings to prevent infections. But the release of antibacterial agents via diffusion from a biomaterial’s surface may not be the most effective approach for combating biofilm formation on implants. With this in mind,
Powered by Innovasium